These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 19729989)
1. MLL fusions: pathways to leukemia. Liu H; Cheng EH; Hsieh JJ Cancer Biol Ther; 2009 Jul; 8(13):1204-11. PubMed ID: 19729989 [TBL] [Abstract][Full Text] [Related]
2. Disordered epigenetic regulation in MLL-related leukemia. Zhang Y; Chen A; Yan XM; Huang G Int J Hematol; 2012 Oct; 96(4):428-37. PubMed ID: 23054645 [TBL] [Abstract][Full Text] [Related]
3. Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia. Liu H; Takeda S; Cheng EH; Hsieh JJ Cell Cycle; 2008 Feb; 7(4):428-35. PubMed ID: 18235233 [TBL] [Abstract][Full Text] [Related]
4. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Drexler HG; Quentmeier H; MacLeod RA Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638 [TBL] [Abstract][Full Text] [Related]
5. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks. Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535 [TBL] [Abstract][Full Text] [Related]
6. The MLL recombinome of acute leukemias in 2013. Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958 [TBL] [Abstract][Full Text] [Related]
7. Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences. Robinson BW; Felix CA Methods Mol Biol; 2009; 538():85-114. PubMed ID: 19277575 [TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of MLL-associated leukemias. Eguchi M; Eguchi-Ishimae M; Greaves M Int J Hematol; 2005 Jul; 82(1):9-20. PubMed ID: 16105754 [TBL] [Abstract][Full Text] [Related]
10. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines. Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655 [TBL] [Abstract][Full Text] [Related]
11. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Strehl S; König M; Meyer C; Schneider B; Harbott J; Jäger U; von Bergh AR; Loncarevic IF; Jarosova M; Schmidt HH; Moore SD; Marschalek R; Haas OA Genes Chromosomes Cancer; 2006 Nov; 45(11):1041-9. PubMed ID: 16897742 [TBL] [Abstract][Full Text] [Related]
18. The MLL recombinome of acute leukemias in 2017. Meyer C; Burmeister T; Gröger D; Tsaur G; Fechina L; Renneville A; Sutton R; Venn NC; Emerenciano M; Pombo-de-Oliveira MS; Barbieri Blunck C; Almeida Lopes B; Zuna J; Trka J; Ballerini P; Lapillonne H; De Braekeleer M; Cazzaniga G; Corral Abascal L; van der Velden VHJ; Delabesse E; Park TS; Oh SH; Silva MLM; Lund-Aho T; Juvonen V; Moore AS; Heidenreich O; Vormoor J; Zerkalenkova E; Olshanskaya Y; Bueno C; Menendez P; Teigler-Schlegel A; Zur Stadt U; Lentes J; Göhring G; Kustanovich A; Aleinikova O; Schäfer BW; Kubetzko S; Madsen HO; Gruhn B; Duarte X; Gameiro P; Lippert E; Bidet A; Cayuela JM; Clappier E; Alonso CN; Zwaan CM; van den Heuvel-Eibrink MM; Izraeli S; Trakhtenbrot L; Archer P; Hancock J; Möricke A; Alten J; Schrappe M; Stanulla M; Strehl S; Attarbaschi A; Dworzak M; Haas OA; Panzer-Grümayer R; Sedék L; Szczepański T; Caye A; Suarez L; Cavé H; Marschalek R Leukemia; 2018 Feb; 32(2):273-284. PubMed ID: 28701730 [TBL] [Abstract][Full Text] [Related]
19. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL Cancer Cell; 2011 Nov; 20(5):563-75. PubMed ID: 22094252 [TBL] [Abstract][Full Text] [Related]
20. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Kurosu T; Tsuji K; Ohki M; Miki T; Yamamoto M; Kakihana K; Koyama T; Taniguchi S; Miura O Int J Hematol; 2008 Sep; 88(2):192-196. PubMed ID: 18642054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]